Sham clinical studies, slush funds, luxury gifts, and shell companies: A new review shows how pharma firms allegedly bribed their way to drug approvals and sales.

Powerful institutions are using covert tactics to shape how they are portrayed online.

Five federal transparency failings – FOIA shortcomings, weak congressional oversight, dark money in elections, inadequate lobbying disclosure and secrecy in court – harm our health.

Emails reveal Wuhan virologist Zhengli Shi asked a U.S. collaborator to hand-carry antibodies to China, bypassing formal shipping protocols.

Documents show scientists across multiple U.S.-funded projects proposed altering spike proteins and cleavage sites in bat viruses — work that echoed ideas later floated in the controversial DEFUSE proposal

The Trump administration yesterday handed Bayer another win, urging the Supreme Court in a new brief to side with the German pesticide company in a high-stakes legal case that could wipe out thousands of cancer lawsuits. Three out of nine U.S. officials who signed the brief previously worked for law firms that have represented Bayer.

A study reveals that early 2000s air pollution exposure significantly impaired older adults' memory by 2011, equating to years of cognitive aging, regardless of subsequent air quality improvements.

Our review of Bayer’s access in Washington found 16 key administration officials with ties to Bayer’s lobbying or legal network. Bayer and its lobbyists have access to people in power at the White House, U.S. Department of Agriculture, the Environmental Protection Agency and even those in high level positions closest to Trump.

Here we list Bayer's 13 lobbying firms and the company’s in-house lobbyists.

A single exposure to a toxic agricultural fungicide during pregnancy can echo through 20 generations — with inherited disease risks from kidney disease to infertility not fading, but worsening over time, according to groundbreaking study reports.